Maternal haemodynamics at elective caesarean section: a randomised comparison of oxytocin 5-unit bolus and placebo infusion with oxytocin 5-unit bolus and 30-unit infusion

International Journal of Obstetric Anesthesia

Volumn 19, Issue 2, 2010, Pages 155-160

  McLeod, G ^a   Munishankar, B ^a   MacGregor, H ^a   Murphy, D J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bioimpedance; Caesarean section; Maternal haemodynamics; Oxytocin

Indexed keywords

OXYTOCIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BOLUS INJECTION; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; VENOUS RETURN;

ADULT; ANALYSIS OF VARIANCE; ANESTHESIA, SPINAL; AREA UNDER CURVE; CARDIOGRAPHY, IMPEDANCE; CESAREAN SECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMICS; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; OXYGEN; OXYTOCICS; OXYTOCIN; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949774658     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2009.08.005     Document Type: Article

References (14)

1. Archer T.L., Knape K., Liles D., Wheeler A.S., and Carter B. The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: findings in six cases. Int J Obstet Anesth 17 (2008) 247-254
2. Svanstrom M.C., Biber B., Hanes M., Johansson G., Naslund U., and Balfors E.M. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth 100 (2008) 683-689
3. In: Lewis G., and Drife J. (Eds). Why Mothers Die 1997-1999. The fifth report of the confidential enquiries into maternal deaths in the United Kingdom (2001), RCOG Press, London
4. Bolton T.J., Randall K., and Yentis S.M. Effect of the confidential enquiries into maternal deaths on the use of Syntocinon at Caesarean section in the UK. Anaesthesia 58 (2003) 277-279
5. Thomas J.S., Koh S.H., and Cooper G.M. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth 98 (2007) 116-119
6. Sartain J.B., Barry J.J., Howat P.W., McCormack D.I., and Bryan M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. Br J Anaesth 101 (2008) 822-826
7. Lewis, G, ed. Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer- 2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: The Confidential Enquiry into Maternal and Child Health (CEMACH); 2007.
8. Knight M, Kurinczuk JJ, Spark P, Brocklehurst P. United Kingdom Obstetric Surveillance System (UKOSS) annual report 2007. Oxford: National Perinatal Epidemiology Unit.
9. Murphy D.J., MacGregor H., Munishankar B., and McLeod G. A randomised controlled trial of oxytocin 5IU and placebo infusion versus oxytocin 5IU and 30IU infusion for the control of blood loss at elective caesarean section-Pilot study. ISRCTN 40302163. Eur J Obstet Gynecol Reprod Biol 142 (2009) 30-33
10. Ngan Kee W.D., Khaw K.S., and Ng F.F. Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for Caesarean section. Br J Anaesth 92 (2004) 469-474
11. Riley E.T. Spinal anaesthesia for Caesarean delivery: keep the pressure up and don't spare the vasoconstrictors. Br J Anaesth 92 (2004) 459-460
12. Wennberg E., and Frid I. Haemodynamic changes during epidural caesarean delivery. Int J Obstet Anesth 3 (1994) 16-19
13. Pinder A.J., Dresner M., Calow C., O'Riordan J., and Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth 11 (2002) 156-159
14. Moshkovitz Y., Kaluski E., Milo O., Vered Z., and Cotter G. Recent developments in cardiac output determination by bioimpedance: comparison with invasive cardiac output and potential cardiovascular applications. Curr Opin Cardiol 19 (2004) 229-237